GB2471973A — Nasal delivery device
Assigned to Optinose AS · Expires 2011-01-19 · 15y expired
What this patent protects
A nasal delivery device for and a method of delivering substance to a nasal airway of a subject, the nasal delivery device comprising: a mouthpiece 19 through which the subject in use exhales to cause closure of the oropharyngeal velum of the subject; a nosepiece 17 for fitting t…
USPTO Abstract
A nasal delivery device for and a method of delivering substance to a nasal airway of a subject, the nasal delivery device comprising: a mouthpiece 19 through which the subject in use exhales to cause closure of the oropharyngeal velum of the subject; a nosepiece 17 for fitting to a nostril of a subject, the nosepiece 17 including a nozzle through which substance is in use delivered to the nasal airway; and a manually-actuatable substance supply 20 unit for delivering substance through the nozzle of the nosepiece 17. In one embodiment the device further comprises a breath actuated latch mechanism 23.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.